SpringWorks Therapeutics: 4Q Earnings Snapshot

February 25, 2021 GMT

STAMFORD, Conn. (AP) _ SpringWorks Therapeutics Inc. (SWTX) on Thursday reported fourth-quarter net income of $11.3 million, after reporting a loss in the same period a year earlier.

The Stamford, Connecticut-based company said it had profit of 24 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 8 cents per share.

The biopharmaceutical company posted revenue of $35 million in the period.

For the year, the company reported that its loss narrowed to $45.6 million, or $1.05 per share. Revenue was reported as $35 million.

SpringWorks Therapeutics shares have risen 29% since the beginning of the year. The stock has more than doubled in the last 12 months.



This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWTX at https://www.zacks.com/ap/SWTX